The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antithrombin-Global Market Insights and Sales Trends 2025
Synopsis
The global Antithrombin market size is expected to reach US$ 691.6 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antithrombin in various end use industries. The expanding demands from the Diagnostics, Therapeutics and Research,, are propelling Antithrombin market. Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lyophilized segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antithrombin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antithrombin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antithrombin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antithrombin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antithrombin covered in this report include Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc. and Lee Biosolutions, etc.
The global Antithrombin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions
Global Antithrombin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antithrombin market, Segment by Type:
Liquid
Lyophilized
Global Antithrombin market, by Application
Diagnostics
Therapeutics
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antithrombin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Antithrombin market size is expected to reach US$ 691.6 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antithrombin in various end use industries. The expanding demands from the Diagnostics, Therapeutics and Research,, are propelling Antithrombin market. Liquid, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lyophilized segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antithrombin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antithrombin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antithrombin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antithrombin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antithrombin covered in this report include Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc. and Lee Biosolutions, etc.
The global Antithrombin market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions
Global Antithrombin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antithrombin market, Segment by Type:
Liquid
Lyophilized
Global Antithrombin market, by Application
Diagnostics
Therapeutics
Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antithrombin companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Antithrombin
1.1 Antithrombin Market Overview
1.1.1 Antithrombin Product Scope
1.1.2 Antithrombin Market Status and Outlook
1.2 Global Antithrombin Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Antithrombin Market Size by Region (2018-2029)
1.4 Global Antithrombin Historic Market Size by Region (2018-2023)
1.5 Global Antithrombin Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Antithrombin Market Size (2018-2029)
1.6.1 North America Antithrombin Market Size (2018-2029)
1.6.2 Europe Antithrombin Market Size (2018-2029)
1.6.3 Asia-Pacific Antithrombin Market Size (2018-2029)
1.6.4 Latin America Antithrombin Market Size (2018-2029)
1.6.5 Middle East & Africa Antithrombin Market Size (2018-2029)
2 Antithrombin Market by Type
2.1 Introduction
2.1.1 Liquid
2.1.2 Lyophilized
2.2 Global Antithrombin Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Antithrombin Historic Market Size by Type (2018-2023)
2.2.2 Global Antithrombin Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Antithrombin Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Antithrombin Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Antithrombin Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Antithrombin Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Antithrombin Revenue Breakdown by Type (2018-2029)
3 Antithrombin Market Overview by Application
3.1 Introduction
3.1.1 Diagnostics
3.1.2 Therapeutics
3.1.3 Research
3.2 Global Antithrombin Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Antithrombin Historic Market Size by Application (2018-2023)
3.2.2 Global Antithrombin Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Antithrombin Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Antithrombin Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Antithrombin Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Antithrombin Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Antithrombin Revenue Breakdown by Application (2018-2029)
4 Antithrombin Competition Analysis by Players
4.1 Global Antithrombin Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antithrombin as of 2022)
4.3 Date of Key Players Enter into Antithrombin Market
4.4 Global Top Players Antithrombin Headquarters and Area Served
4.5 Key Players Antithrombin Product Solution and Service
4.6 Competitive Status
4.6.1 Antithrombin Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Grifols
5.1.1 Grifols Profile
5.1.2 Grifols Main Business
5.1.3 Grifols Antithrombin Products, Services and Solutions
5.1.4 Grifols Antithrombin Revenue (US$ Million) & (2018-2023)
5.1.5 Grifols Recent Developments
5.2 rEVO Biologics Inc.
5.2.1 rEVO Biologics Inc. Profile
5.2.2 rEVO Biologics Inc. Main Business
5.2.3 rEVO Biologics Inc. Antithrombin Products, Services and Solutions
5.2.4 rEVO Biologics Inc. Antithrombin Revenue (US$ Million) & (2018-2023)
5.2.5 rEVO Biologics Inc. Recent Developments
5.3 Takeda
5.3.1 Takeda Profile
5.3.2 Takeda Main Business
5.3.3 Takeda Antithrombin Products, Services and Solutions
5.3.4 Takeda Antithrombin Revenue (US$ Million) & (2018-2023)
5.3.5 Kedrion S.p.A. Recent Developments
5.4 Kedrion S.p.A.
5.4.1 Kedrion S.p.A. Profile
5.4.2 Kedrion S.p.A. Main Business
5.4.3 Kedrion S.p.A. Antithrombin Products, Services and Solutions
5.4.4 Kedrion S.p.A. Antithrombin Revenue (US$ Million) & (2018-2023)
5.4.5 Kedrion S.p.A. Recent Developments
5.5 CSL Limited
5.5.1 CSL Limited Profile
5.5.2 CSL Limited Main Business
5.5.3 CSL Limited Antithrombin Products, Services and Solutions
5.5.4 CSL Limited Antithrombin Revenue (US$ Million) & (2018-2023)
5.5.5 CSL Limited Recent Developments
5.6 Scripps Laboratories Inc.
5.6.1 Scripps Laboratories Inc. Profile
5.6.2 Scripps Laboratories Inc. Main Business
5.6.3 Scripps Laboratories Inc. Antithrombin Products, Services and Solutions
5.6.4 Scripps Laboratories Inc. Antithrombin Revenue (US$ Million) & (2018-2023)
5.6.5 Scripps Laboratories Inc. Recent Developments
5.7 Lee Biosolutions
5.7.1 Lee Biosolutions Profile
5.7.2 Lee Biosolutions Main Business
5.7.3 Lee Biosolutions Antithrombin Products, Services and Solutions
5.7.4 Lee Biosolutions Antithrombin Revenue (US$ Million) & (2018-2023)
5.7.5 Lee Biosolutions Recent Developments
6 North America
6.1 North America Antithrombin Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Antithrombin Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antithrombin Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antithrombin Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antithrombin Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antithrombin Market Dynamics
11.1 Antithrombin Industry Trends
11.2 Antithrombin Market Drivers
11.3 Antithrombin Market Challenges
11.4 Antithrombin Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
